APA (7th ed.) Citation

Yang, Y., Yang, Y., Xie, Q., Xie, Q., Lv, T., Lv, T., . . . Wu, H. (2025). Postoperative adjuvant hepatic arterial infusion chemotherapy with gemcitabine-cisplatin sequential capecitabine combined with PDL1 inhibitors in resected high-risk intrahepatic cholangiocarcinom: Study protocol for a prospective, multicenter, single-arm, phase 2 trial (HgcCP trial). Frontiers Media S.A.

Chicago Style (17th ed.) Citation

Yang, Ying, et al. Postoperative Adjuvant Hepatic Arterial Infusion Chemotherapy with Gemcitabine-cisplatin Sequential Capecitabine Combined with PDL1 Inhibitors in Resected High-risk Intrahepatic Cholangiocarcinom: Study Protocol for a Prospective, Multicenter, Single-arm, Phase 2 Trial (HgcCP Trial). Frontiers Media S.A, 2025.

MLA (9th ed.) Citation

Yang, Ying, et al. Postoperative Adjuvant Hepatic Arterial Infusion Chemotherapy with Gemcitabine-cisplatin Sequential Capecitabine Combined with PDL1 Inhibitors in Resected High-risk Intrahepatic Cholangiocarcinom: Study Protocol for a Prospective, Multicenter, Single-arm, Phase 2 Trial (HgcCP Trial). Frontiers Media S.A, 2025.